US Court Rules In Favor Of Viatris For Interchangeable Semglee

Partners Biocon and Viatris To Continue To Market Insulin Glargine Biosimilar

Court Ruling
Sanofi loses to Viatris as US Court finds challenged claims unpatentable • Source: Alamy

More from Biosimilars

More from Products